Indian pharma firm Wanbury gains on product launch plans
** Wanbury's shares WANB.NS rise 9%, set for fifth straight session of gains ** Pharma co to launch two new products for formulation, including iron tablets and Ketamine ** Over 255,000 shares traded, 1.6x WANB's 30-day avg ** Stock has surged ~41% in March vs a ~10% rise in Nifty pharma index .NIPHARM (Reporting by Ashna Teresa Britto in Bengaluru) ((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))
Recent news on Wanbury
See all newsBrief: Wanbury Ltd Receives 9 “No DMF Deficiency” Letters From USFDA For Metformin HCl
Brief: Wanbury Files New Drug Master File In South Africa For Tramadol Hcl API
Brief: Wanbury June-Quarter PAT 32.4 Million Rupees
Brief: Wanbury Receives No DMF Deficiency Letter From USFDA For Multiple Andas
Brief: Wanbury Says Completion Of US FDA Inspection At Tanuku Facility